Learn about the licensing considerations, continuing obligations, and risk related to physical security in the cannabis industry, from mapping your business to liaising with law enforcement, and from environmental and procedural security to best practices in security employee training, join us to go through the intricacies of security in the cannabis industry.
In this session, hear from attorneys who are actively working on applications in the Garden State and with clients who are investing in New Jersey or otherwise gearing up for future submissions. Learn about unique-to-New Jersey license types, such as the “Conditional License,” enabling prospective operators to apply for a license without site control (subject to income restrictions), the “Micro-license,” a 2500 square foot facility for which there are no caps (subject to residency requirements), priorities in licensing, and creative opportunities to participate in the market distinct from ownership (via “Financial Source Agreement” or “Management Services Agreement”). Also learn about how the regulatory process is unfolding and how administrative delays are impacting the licensing process and accompanying operational timelines and legal transactions.
Since 2014, Americans For Safe Access’s annual State of the States report has assessed the strength of medical cannabis programs by assigning grades to each of the 50 states, the District of Columbia and the U.S. territories. The 2021 Americans for Safe Access State of the States Report will feature new report card formats and scoring that highlight key areas of medical cannabis policy that affect patient needs.
This webinar provides an overview of the appellate process. Attendees will become acquainted with the phases of an appeal as well as key concepts like error preservation, the record, amicus practice, standards of review, and more.
The recreational cannabis industry has emerged in Spain. We will explore the process to get cultivation licenses for medical cannabis producers, leading products in the market, the social impacts of cannabis clubs, and the realities of the hemp market.
This one hour session will touch on the legal framework of recreational and medicinal cannabis in Switzerland and provide a high-level overview of the newest developments, the challenges, as well as the opportunities in Switzerland’s dynamic cannabis market.
Niall will discuss cannabis jurisdiction, legislation, regulation, Medical Cannabis Access Programme (MCAP, the Specified Controlled Drugs (Cannabis-Based Medical Products), indications, CBD - Novel Foods (Conflict of Laws), and adult use in the Republic of Ireland.